The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2015
Filed:
Feb. 13, 2013
Applicant:
The Board of Trustees of the Leland Stanford Junior University, Palo Alto, CA (US);
Inventors:
Yohannes T. Ghebremariam, Santa Clara, CA (US);
John P. Cooke, Palo Alto, CA (US);
Assignee:
The Board of Trustees of the Leland Stanford Junior University, Palo Alto, CA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/542 (2006.01); A61K 31/4439 (2006.01); A61K 31/437 (2006.01); A61K 31/428 (2006.01); A61M 11/04 (2006.01); A61M 15/00 (2006.01); A61M 16/14 (2006.01); A61K 31/444 (2006.01);
U.S. Cl.
CPC ...
A61K 31/542 (2013.01); A61K 31/4439 (2013.01); A61K 31/437 (2013.01); A61K 31/428 (2013.01); A61M 11/04 (2013.01); A61M 15/00 (2013.01); A61M 16/14 (2013.01); A61M 15/009 (2013.01); A61K 9/00 (2013.01); A61K 31/444 (2013.01);
Abstract
The present disclosure provides DDAH modulators. Thus, the present disclosure provides a method of treating a patient suffering from a disorder characterized by excessive NO production and/or elevated DDAH activity, the method comprising administering to said patient an effective amount of a compound of one of formulae I-X. The present disclosure also provides a pharmaceutical composition comprising a compound of one of formulae I-X.